SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-24-167200
Filing Date
2024-06-25
Accepted
2024-06-24 20:14:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-1 d835977df1.htm F-1 373174
2 EX-5.1 d835977dex51.htm EX-5.1 49734
3 EX-23.1 d835977dex231.htm EX-23.1 2576
4 EX-23.2 d835977dex232.htm EX-23.2 2061
5 EX-FILING FEES d835977dexfilingfees.htm EX-FILING FEES 33934
6 GRAPHIC g835977g0624075929743.jpg GRAPHIC 3107
7 GRAPHIC g835977g0624075929969.jpg GRAPHIC 7125
8 GRAPHIC g835977g58f53.jpg GRAPHIC 24453
  Complete submission text file 0001193125-24-167200.txt   510913
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-1 | Act: 33 | File No.: 333-280447 | Film No.: 241065951
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)